Drug intelligence / Profile preview

Lacjet

Development stage: Unknown
Lead developer: Amvia Biotech
Modality: Small Molecules
Administration: Oral

Overview

Lacjet is an Ayurvedic laxative formulation developed by Amvia Biotech for the management of constipation. It is presented as an oral powder and is available in 50 gm and 100 gm packaging. As an Ayurvedic preparation, it likely utilizes a blend of traditional herbal ingredients known for their prokinetic or osmotic laxative properties, although the specific active constituents and precise mechanism of action are not publicly detailed in the company's pipeline documentation. It is categorized as a natural product intended to promote bowel regularity.

Brand names: Lacjet
Other names: Ayurvedic Laxative

Beyond the preview

Go deeper on Lacjet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lacjet.

Explore the full profile